Agents for treating disorders involving modulation of ryanodine receptors

The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BERTRAND MARC, VILLENEUVE NICOLE, WEBB YAEL, YAN JIAMING, BELVEDERE SANDRO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BERTRAND MARC
VILLENEUVE NICOLE
WEBB YAEL
YAN JIAMING
BELVEDERE SANDRO
description The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN104350045A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN104350045A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN104350045A3</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHPxIOof1gcIkbYPKEXRiyfvJTSbEoi7YXct-HsVfICngZlZu2s_I5lCYgETDJZphpiVJaIoZFq4LF_34Pgsn8wEnEBegThmQhCcsBqLbt0qhaK4-3Hj9ufTfbgcsPKIWsOEhDYOt6Nvm877tuubf543Rwc1fw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Agents for treating disorders involving modulation of ryanodine receptors</title><source>esp@cenet</source><creator>BERTRAND MARC ; VILLENEUVE NICOLE ; WEBB YAEL ; YAN JIAMING ; BELVEDERE SANDRO</creator><creatorcontrib>BERTRAND MARC ; VILLENEUVE NICOLE ; WEBB YAEL ; YAN JIAMING ; BELVEDERE SANDRO</creatorcontrib><description>The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150211&amp;DB=EPODOC&amp;CC=CN&amp;NR=104350045A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150211&amp;DB=EPODOC&amp;CC=CN&amp;NR=104350045A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERTRAND MARC</creatorcontrib><creatorcontrib>VILLENEUVE NICOLE</creatorcontrib><creatorcontrib>WEBB YAEL</creatorcontrib><creatorcontrib>YAN JIAMING</creatorcontrib><creatorcontrib>BELVEDERE SANDRO</creatorcontrib><title>Agents for treating disorders involving modulation of ryanodine receptors</title><description>The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHPxIOof1gcIkbYPKEXRiyfvJTSbEoi7YXct-HsVfICngZlZu2s_I5lCYgETDJZphpiVJaIoZFq4LF_34Pgsn8wEnEBegThmQhCcsBqLbt0qhaK4-3Hj9ufTfbgcsPKIWsOEhDYOt6Nvm877tuubf543Rwc1fw</recordid><startdate>20150211</startdate><enddate>20150211</enddate><creator>BERTRAND MARC</creator><creator>VILLENEUVE NICOLE</creator><creator>WEBB YAEL</creator><creator>YAN JIAMING</creator><creator>BELVEDERE SANDRO</creator><scope>EVB</scope></search><sort><creationdate>20150211</creationdate><title>Agents for treating disorders involving modulation of ryanodine receptors</title><author>BERTRAND MARC ; VILLENEUVE NICOLE ; WEBB YAEL ; YAN JIAMING ; BELVEDERE SANDRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN104350045A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERTRAND MARC</creatorcontrib><creatorcontrib>VILLENEUVE NICOLE</creatorcontrib><creatorcontrib>WEBB YAEL</creatorcontrib><creatorcontrib>YAN JIAMING</creatorcontrib><creatorcontrib>BELVEDERE SANDRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERTRAND MARC</au><au>VILLENEUVE NICOLE</au><au>WEBB YAEL</au><au>YAN JIAMING</au><au>BELVEDERE SANDRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Agents for treating disorders involving modulation of ryanodine receptors</title><date>2015-02-11</date><risdate>2015</risdate><abstract>The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CN104350045A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Agents for treating disorders involving modulation of ryanodine receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T12%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERTRAND%20MARC&rft.date=2015-02-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN104350045A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true